Paysign, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Paysign, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Finance & Banking sector, Paysign, Inc. has logged 151 reports. Market capitalisation: €703.5m. The latest transaction was disclosed on 4 September 2026 (Attribution). Among the most active insiders: Newcomer Mark. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,238 of 29,063 companies
FCF yld 6.3%
Earn yld 1.1%
EV/EBITDA 45.2x
ROE 31%
Gross mgn 59%
Net mgn 9.2%
Debt/EBITDA 0.4x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
All Executives151 Thresholds0 Prospectus0 Other0
Declarations 151 total
◆ PRES., PATIENT AFFORDABILITY · Executives · 13 Nov 2025
233,333 shares 0Common Stock SEC:0001683168-26-006985:0
● Chief Technology Officer · Executives · 18 May 2026
12,369 shares @ US$5.865 15.5% of flow Common Stock SEC:0001683168-26-006983:0
▼ Chief Technology Officer · Executives · 29 May 2026
10,000 shares @ US$7.302 15.6% of flow Common Stock SEC:0001683168-26-006983:1
▼ Chief Technology Officer · Executives · 1 Jun 2026
3,000 shares @ US$7.80 5.0% of flow Common Stock SEC:0001683168-26-006983:2
● Chief Technology Officer · Executives · 30 Jun 2026
11,579 shares @ US$8.19 0.014% mcap 20.6% of flow Common Stock SEC:0001683168-26-006983:3
● Chief Technology Officer · Executives · 31 Jul 2026
22,430 shares @ US$8.96 0.029% mcap 43.3% of flow Common Stock SEC:0001683168-26-006983:4
▼ PRES., PATIENT AFFORDABILITY · Executives · 3 Feb 2026
15,057 shares @ US$4.16 15.3% of flow Common Stock SEC:0001683168-26-006985:1
● PRES., PATIENT AFFORDABILITY · Executives · 22 May 2026
50,681 shares @ US$6.72 84.7% of flow Common Stock SEC:0001683168-26-006985:2
▼ Chief Financial Officer · Executives · 12 Aug 2026
35,000 shares @ US$12.6182 0.061% mcap 25.3% of flow Common Stock SEC:0001683168-26-006492:0
▼ CEO · Executives · 6 Aug 2026
150,000 shares @ US$11.8757 0.25% mcap 31.4% of flow Common Stock SEC:0001683168-26-006116:0
◇ Director · Executives · 4 Aug 2026
20,000 shares 0Common Stock SEC:0001683168-26-006072:0
◇ Director · Executives · 4 Aug 2026
20,000 shares 0Common Stock SEC:0001683168-26-006073:0
◇ Director · Executives · 4 Aug 2026
20,000 shares 0Common Stock SEC:0001683168-26-006074:0
◇ Director · Executives · 4 Aug 2026
20,000 shares 0Common Stock SEC:0001683168-26-006075:0
● Chief Legal Officer · Executives · 31 Jul 2026
25,184 shares @ US$8.96 0.031% mcap 32.2% of flow Common Stock SEC:0001683168-26-005954:1
● Chief Payments Officer · Executives · 31 Jul 2026
25,185 shares @ US$8.96 0.031% mcap 43.3% of flow Common Stock SEC:0001683168-26-005955:1
● CEO · Executives · 31 Jul 2026
59,025 shares @ US$8.96 0.073% mcap 13.7% of flow Common Stock SEC:0001683168-26-005956:1
◇ Chief Payments Officer · Executives · 31 Jul 2026
64,000 shares 0Common Stock SEC:0001683168-26-005955:0
◇ Chief Financial Officer · Executives · 31 Jul 2026
64,000 shares 0Common Stock SEC:0001683168-26-005952:0
◇ EVP, EFT Operations · Executives · 31 Jul 2026
36,000 shares 0Common Stock SEC:0001683168-26-005953:0
◇ CEO · Executives · 31 Jul 2026
150,000 shares 0Common Stock SEC:0001683168-26-005956:0
◇ Chief Legal Officer · Executives · 31 Jul 2026
64,000 shares 0Common Stock SEC:0001683168-26-005954:0
● Chief Financial Officer · Executives · 31 Jul 2026
28,506 shares @ US$8.96 0.035% mcap 19.6% of flow Common Stock SEC:0001683168-26-005952:1
● EVP, EFT Operations · Executives · 31 Jul 2026
13,780 shares @ US$8.96 0.017% mcap 10.2% of flow Common Stock SEC:0001683168-26-005953:1
▼ Director · Executives · 11 Jun 2026
10,000 shares @ US$7.095 0.0098% mcap 18.9% of flow Common Stock SEC:0001683168-26-005887:2
25 of 151 declarations
Load more (126 remaining) 关于 Paysign, Inc. Paysign, Inc. 是一家在美国纳斯达克市场(美国)上市的公司,专注于预付卡支付解决方案和集成支付处理服务。该公司总部位于内华达州亨德森,于 1995 年 8 月 24 日注册成立。对于讲法语的投资者而言,Paysign 应被视为利基金融科技和支付基础设施提供商,而非传统银行:它为需要快速支付、可追溯性和严格合规控制的客户设计、推出和运营实体和虚拟预付卡项目,以及相关的处理堆栈。
该公司的商业模式主要是 B2B/B2B2C。历史上,Paysign 一直为企业、消费者和政府客户提供预付卡产品和处理服务。最近,管理层强调了两个战略增长引擎:制药行业的患者可负担性项目和血浆采集中心的捐赠者补偿解决方案。这种垂直化方法使 Paysign 置身于受监管的工作流程中,其中支付准确性、运营可靠性和用户体验至关重要。Paysign 将自己定位为全方位服务合作伙伴,能够处理项目设计、卡片发行、交易处理、运营和某些支持功能。
从竞争角度来看,Paysign 在一个分散的市场中运营,该市场包括大型支付处理商、卡片发行商、礼品卡专家和专注于特定垂直领域的金融科技供应商。其竞争优势更多在于专业化而非纯粹的规模:该公司瞄准定制项目架构和深度运营集成能产生粘性的终端市场。管理层还强调了数百万张预付卡的组合,这表明其利基市场内拥有重要的安装基础。
从地理上看,该业务主要集中在美国,尽管其服务可能支持拥有更广泛运营足迹的客户。该公司总部仍设在内华达州亨德森,截至 2025 年底报告约有 226 名员工和独立承包商。
近期发展对投资案例至关重要。2026 年 3 月 24 日,Paysign 报告 2025 财年收入为 82.0 million 美元,同比增长 40.5%,利润率因组合改善而扩大。该公司还报告了血浆中心数量和活跃患者可负担性项目的增长,巩固了其最高增长垂直领域的势头。此外,Paysign 继续出现在 SEC Form 4 内部交易备案的稳定流中,这使得市场密切关注内部人持股和交易活动的变化。